Reckitt Benckiser Group (RBGLY)
(Delayed Data from OTC)
$12.20 USD
+0.12 (0.99%)
Updated Sep 23, 2024 03:59 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Income Statements
Fiscal Year end for Reckitt Benckiser Group PLC falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 18,164 | 17,877 | 18,198 | 17,967 | 16,403 |
Cost Of Goods | NA | 7,535 | 7,643 | 7,136 | 6,471 |
Gross Profit | NA | 10,342 | 10,555 | 10,831 | 9,932 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 6,323 | 11,661 | 8,057 | 12,427 |
Income After Depreciation & Amortization | 0 | 4,019 | -1,106 | 2,773 | -2,495 |
Non-Operating Income | NA | 59 | 1,049 | 98 | 206 |
Interest Expense | NA | 284 | 301 | 466 | 401 |
Pretax Income | NA | 3,794 | -358 | 2,405 | -2,690 |
Income Taxes | NA | 879 | -286 | 924 | 849 |
Minority Interest | NA | 24 | 15 | 21 | 17 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 2,032 | 2,914 | -72 | 1,480 | -3,540 |
Extras & Discontinued Operations | 11 | -9 | 43 | 64 | -1,147 |
Net Income (GAAP) | 2,043 | 2,882 | -44 | 1,524 | -4,703 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 4,769 | -444 | 4,644 | 4,597 |
Depreciation & Amortization (Cash Flow) | NA | 751 | 661 | 1,871 | 7,092 |
Income After Depreciation & Amortization | 0 | 4,019 | -1,106 | 2,773 | -2,495 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 3,592.04 | 3,587.47 | 3,569.00 | 3,568.85 | 3,543.39 |
Diluted EPS Before Non-Recurring Items | 0.80 | 0.84 | 0.80 | 0.84 | 0.90 |
Diluted Net EPS (GAAP) | 0.57 | 0.80 | -0.01 | 0.43 | -1.33 |
Fiscal Year end for Reckitt Benckiser Group PLC falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |